Dossier · OII · Dormant
OII · Oceaneering International Inc. · Stock research
Last analysed ·
Current thesis
Offshore earnings inflection (Q2 adj EBITDA $115M, FY guide $400–440M) is now fully re-rated: Citi's 2026-08-11 raise to $52 puts the anchor target at the tape, closing the sell-side gap that drove the July leg. Price $52.20 on 2026-08-14 with RSI 50.1 and three insider sales 07-30 to 08-07. Narrative maturing; next binary is Q3 in late October.
Kill line
A weekly close below $46 re-enters the 2026-07-22 earnings gap and forfeits the post-print consolidation band; a Q3 adjusted EBITDA print under the guided $115–125M in late October would confirm the cyclical leg is rolling over.
Pick status
Open commitment catalyst in 14dscored if the kill line above fires How this is scored →Latest analysis and events for OII —
As of 16 August 2026, the latest FrontierPicks analysis for Oceaneering International Inc. (OII): Offshore earnings inflection (Q2 adj EBITDA $115M, FY guide $400–440M) is now fully re-rated: Citi's 2026-08-11 raise to $52 puts the anchor target at the tape, closing the sell-side gap that drove the July leg. Price $52.20 on 2026-08-14 with RSI 50.1 and three insider sales 07-30 to 08-07. Narrative maturing; next binary is Q3 in late October.
Kill line: A weekly close below $46 re-enters the 2026-07-22 earnings gap and forfeits the post-print consolidation band; a Q3 adjusted EBITDA print under the guided $115–125M in late October would confirm the cyclical leg is rolling over.
Next dated event on file: — catalyst in 14d.
Current Thesis
The July frame — an offshore-services earnings inflection with a defense-autonomy option bolted on — is intact, and one leg of it has now been paid out. The gap between the tape and the sell-side, which was the mechanical driver of the post-print move, has closed: Barclays lifted its target from $23 to $47 on 2026-07-27, and Citigroup raised to $52 at Neutral on 2026-08-11, against a 2026-08-14 close of $52.20. Both remain non-Buy ratings. Price sits 1.0% under the 52-week high of $52.73 with RSI(14) at 50.1 and a three-month return of +37.9% — momentum has gone flat at the top of the range rather than extending. Three insiders sold on the open market between 2026-07-30 and 2026-08-07. The narrative is maturing — the story is well known, price is still working, but the flow that drove it is moderating and the next hard fundamental binary is the Q3 print in late October.
Bullish and bearish views on Oceaneering International Inc.
The model's bull view on Oceaneering International Inc. (OII), in brief: The inflection was in the numbers, not the framing. The bear view: The upgrade cycle is no longer a gap to close. Both cases follow in full.
Bull Case
- The inflection was in the numbers, not the framing. Q2 2026, reported 2026-07-22: adjusted EPS $0.63 vs $0.46 consensus; revenue $768.184M vs $734.780M estimated; adjusted EBITDA $115M, the highest quarterly figure since Q3 2015.
- Forward guidance moved with it. On the 2026-07-23 call, FY2026 consolidated adjusted EBITDA guidance was raised to $400–440M and Q3 was guided to $115–125M. That Q3 range is the number the October print is graded against.
- The re-rate the July note flagged actually happened. From a $22–34 target band standing on 2026-07-23, Barclays went to $47 on 2026-07-27 and Citigroup to $52 on 2026-08-11. This is a measured, not inferred, catch-up of roughly 90% in the anchor target inside three weeks.
- Order and balance-sheet housekeeping on the Q2 call. Management cited new contract awards including ROV services in Brazil, and an extension of debt maturities alongside an upsized credit facility. Stated capital-allocation order: organic growth, then inorganic, then opportunistic buybacks.
- The defense leg gets its own stage. Following the mid-July DIU Combat Autonomous Maritime Platform selection with KONGSBERG for XLUUV work (announced 2026-07-14), CEO Rod Larson is scheduled to present the Aerospace & Defense Technologies segment at the Gabelli Aerospace & Defense Symposium in New York on 2026-09-10 — the first dedicated defense-investor audience for a story that has so far been told to energy accounts.
Bear Case
- The upgrade cycle is no longer a gap to close. Citigroup's $52 target and the 2026-08-14 close of $52.20 are effectively the same number, and both live ratings in the last 30 days are Equal-Weight and Neutral. The re-rating bid that carried July has to be replaced by something else.
- director Paul B. Murphy Jr. A Form 144 was also filed in the period.
- Momentum flattened where it should be strongest. RSI(14) of 50.1 on 2026-08-14 with price 1.0% off the 52-week high describes distribution-shaped chop, not an impulse leg.
- A named soft segment. Integrity Management and Digital Solutions posted lower Q2 revenue and operating income on reduced activity and higher personnel costs, with Middle East weakness flagged on the 2026-07-23 call. It was offset by OPG and SSR in Q2; it need not be in Q3.
- Retail-attention clustering already appeared once. Benzinga's 2026-07-27 "Top 3 Energy Stocks That May Implode This Month" listed OII on an RSI above 70 — mainstream overbought coverage arriving inside a week of the print.
- No fundamental event inside 30 days. The three scheduled September appearances are conference panels and investor meetings, not disclosure events with numbers attached.
Setup & Price Structure
- Reference levels. 2026-08-14 close $52.20; 52-week high $52.73; three-month return +37.9%; RSI(14) 50.1.
- The July gap is the structure. The 2026-07-22 close of $45.00 gapped to a $51.48 intraday high on 2026-07-23. Three weeks later that gap remains unfilled and price has printed a new high above it.
- Where the tape actually traded in between (inferred). Form 4 weighted-average sale prices of $46.71 (2026-07-30), $47.92 (2026-07-30) and $48.369 (2026-08-07) place the stock in the high-$40s through early August — the lower half of the gap — before the push to $52.73. The insider prints are a public read on the consolidation range, not a view on it.
- The band. Roughly $46 to $52.73 has contained price since the print. A weekly close below $46 puts the stock back inside the earnings gap and gives up every session of the post-print consolidation.
- What breaks the range upward. A weekly close above $52.73 on expanding volume would be a fresh high with the sell-side anchor at $52, which is the configuration that historically forces the next round of target revisions. Not observed as of 2026-08-14.
Catalyst Calendar (next 30 days)
- 2026-09-09 — Barclays Energy-Power Conference, New York. CEO Rod Larson on a panel; Larson, CFO Mike Sumruld and IR meeting institutional investors. First public management commentary since the 2026-07-23 call, and the venue where a Q3 ROV-utilization or vessel-activity pre-read would surface.
- 2026-09-10 — Gabelli Aerospace & Defense Symposium, New York. Larson presenting on the Aerospace & Defense Technologies segment. Tests whether the XLUUV/CAMP work is credited by defense investors or stays an energy-cyclical story with a headline attached.
- 2026-09-24 — TD Cowen Energy Conference, Austin, TX. Sumruld and IR meeting investors. Just outside the 30-day window; listed for completeness.
Elapsed catalysts
- ~late October 2026 (est.) — Q3 2026 print. Not yet scheduled as of 2026-08-16. The graded number is adjusted EBITDA against the $115–125M guide and any move in the $400–440M FY range. (passed 10d ago)
What Would Change Our Mind
The structure that matters is the unfilled 2026-07-22 gap and the $46–$52.73 band built on top of it. Losing that band is the break: a weekly close below $46 re-enters the gap and erases the post-print consolidation, at which point the September conference appearances become a bounce narrative rather than a continuation one. Second, a Q3 adjusted EBITDA print under the guided $115–125M in late October would show the cyclical leg rolling rather than compounding, and would leave a stock trading at the top of its 52-week range with no upgrade cushion beneath it — Citigroup's $52 and Barclays' $47 are now under the tape, not above it. Third, if 2026-09-09 and 2026-09-10 come and go with no incremental defense detail and no target revisions follow, the theme has moved from maturing to saturated and the remaining bid is passive. A fourth, slower signal: continued open-market insider selling above $50, which would extend the 2026-07-30 to 2026-08-07 pattern into the new high rather than leaving it as a one-off around the print.
Correlation Notes
- Crude and offshore capex are the primary factor. Subsea Robotics day-rates and OPG vessel activity track offshore E&P spending; a Brent breakdown transmits to ROV utilization with a lag, and OII trades with the OIH/offshore-services complex on those days.
- The defense leg is a different factor entirely. XLUUV/CAMP exposure correlates to undersea-autonomy sentiment and the KONGSBERG partnership, not to crude. The 2026-09-10 Gabelli slot is the first clean observation of whether the market prices those two legs separately.
- Segment offsetting is internal, not diversification. In Q2 the strength in OPG and SSR covered the IMDS decline. If the cycle turns, both energy segments turn together and the A&D segment is too small to offset it — the correlation inside the P&L is high, whatever the narrative says.
Notes
- Q3 2026 earnings not yet scheduled as of 2026-08-16; Oceaneering has historically reported Q3 in late October and issues a scheduling release ahead of it.
- Guidance is given as consolidated adjusted EBITDA, not EPS — prints are graded against the $400–440M FY range and the $115–125M Q3 range.
- XLUUV/CAMP work under DIU is concept, architecture and design-trade scope with competing awardees; it is narrative optionality, not booked backlog.
- Segment mix drives the print: OPG and Subsea Robotics carry the cycle, while IMDS was the Q2 2026 soft spot on Middle East activity.
Related · shared themes
HUM
Humana Inc.
Margin-over-volume Medicare Advantage reset reclaimed its trend: the 2026-08-24 close of $386.61 is 2.0% above the prior session and back clear of the last 50-day value observed ($378.33, 2026-08-12), with RSI(14) at 64.6 from 52.5. Revision flow idle since Bernstein's 08-14 Buy/$425, and the 2027 number now has a venue — a 2026-12-10 investor update — past both the 09-08/10 conference window and the 11-06 print. The narrative is maturing.
RXO
RXO, Inc.
Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.
CNC
Centene Corporation
Margin-repair guide raise of 2026-07-28 stays fully priced: the 2026-08-24 close of $65.65 is 2.7% under the 2026-08-14 close of $67.47 and 4.5% below the $68.72 52-week high, with no analyst target moved since Argus on 2026-08-11. maturing; the next company-controlled datapoint is Q3, now calendared 2026-10-27.
HNGE
Hinge Health, Inc.
Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.